Original Article
The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel
N Engl J Med 2001; 345:17-24July 5, 2001
- Abstract
Background
Familial hemiplegic migraine, an autosomal dominant disorder characterized by attacks of transient hemiparesis followed by a migraine headache, is divided into pure familial hemiplegic migraine (affecting 80 percent of families) and familial hemiplegic migraine with permanent cerebellar signs (affecting 20 percent of families). Mutations in CACNA1A, which encodes a neuronal calcium channel, are present in 50 percent of families with hemiplegic migraine, including all those with cerebellar signs. We studied the various clinical manifestations associated with mutations in CACNA1A in 28 families with hemiplegic migraine with and without cerebellar signs.
Methods CACNA1A
was analyzed and nine mutations were detected in 15 of 16 probands of families affected by hemiplegic migraine and cerebellar signs, in 2 of 3 subjects with sporadic hemiplegic migraine and cerebellar signs, and in 4 of 12 probands of families affected by pure hemiplegic migraine. Genotyping of probands and relatives identified a total of 117 subjects with mutations whose clinical manifestations were assessed in detail.
Results
Eighty-nine percent of the subjects with mutations had attacks of hemiplegic migraine. One third had severe attacks with coma, prolonged hemiplegia, or both, with full recovery. All nine mutations, including five newly identified ones, were missense mutations. Six mutations were associated with hemiplegic migraine and cerebellar signs, and 83 percent of the subjects with these six mutations had nystagmus, ataxia, or both. Three mutations were associated with pure hemiplegic migraine.
Conclusions
Hemiplegic migraine in subjects with mutations in CACNA1A has a broad clinical spectrum. This clinical variability is partially associated with the various types of mutations.
Media in This Article
Figure 2
Pedigrees.Figure 1
Mutations in CACNA1A Causing Hemiplegic Migraine.Article Activity
- Article
Migraine is a common condition, affecting about 12 percent of the population in Western countries.1-4 In addition to environmental factors, genetic factors have been demonstrated to play a part in the pathogenesis of migraine.5,6 In the two main types of migraine, migraine with aura and migraine without aura,1 the familial aggregation cannot be explained by simple mendelian inheritance patterns. Familial hemiplegic migraine is the only variety of migraine in which a mendelian type of inheritance has been clearly established.1,7-14 This rare variety of migraine with aura is characterized by its autosomal dominant pattern of inheritance and by the presence of some degree of hemiparesis during attacks.1 In contrast to other types of migraine, familial hemiplegic migraine is characterized in some patients by severe coma with prolonged hemiplegia.8,10,11 Some patients have permanent neurologic signs of disease, most often nystagmus and ataxia between attacks. These differences have led clinicians to distinguish families affected by pure hemiplegic migraine from families affected by hemiplegic migraine and cerebellar signs (in which at least one member has nystagmus or ataxia).7-19 Some sporadic cases of hemiplegic migraine with cerebellar signs have also been reported.19,20
Familial hemiplegic migraine is genetically heterogeneous.12,13,17,18 CACNA1A, the first gene that has been associated with the disorder, is located on chromosome 19 and encodes the α1A subunit of voltage-gated P/Q-type calcium channels in neurons.12,14 Thus far, familial hemiplegic migraine with cerebellar signs has been linked to mutations in CACNA1A in all families studied.14,16,19-22 Pure hemiplegic migraine has been associated with mutations in CACNA1A in some families,12,14,17,23 but in others a locus has been mapped on chromosome 1.18,24 In still others the disorder is linked neither to CACNA1A nor to the locus on chromosome 1, suggesting the existence of at least a third locus.18
Eight mutations in CACNA1A have been identified in 18 families affected by hemiplegic migraine and two patients with sporadic hemiplegic migraine.14,19-23 The absence of detailed clinical data on most of the families19 has precluded the description of detailed correlations between genotype and phenotype.
We screened for mutations in CACNA1A in 28 families and 3 subjects with sporadic hemiplegic migraine. Our goal was to obtain a large, homogeneous group of subjects with mutations in CACNA1A that would allow a detailed clinical description of the disorder and of the correlations between genotype and phenotype.
Methods
Subjects and Controls
All subjects provided written informed consent, as required by appropriate committees on the protection of research subjects, and were interviewed and examined by one of us. Diagnostic criteria of the International Headache Society were used to define familial hemiplegic migraine and other varieties of migraine.1 Twenty-eight unrelated families were studied: 16 families affected by hemiplegic migraine with cerebellar signs, defined by the presence of nystagmus, ataxia, or both in at least one member (Families 1 through 16), and 12 families affected by pure hemiplegic migraine, defined by the absence of nystagmus and ataxia in all of the examined members (Families 17 through 28).19 In all of these families, previous data on linkage and haplotypes suggested linkage to chromosome 19, although the data were inconclusive in some small families.19 Three subjects with sporadic hemiplegic migraine with cerebellar signs were also studied (Patients 1, 2, and 3). One hundred healthy spouses of subjects affected by hemiplegic migraine who had the same ethnic background were selected as controls.
Detection of Mutations and Genotyping
DNA was prepared according to standard procedures. Screening for mutations was performed in the proband from each of the 28 families and in subjects with sporadic cases with the use of single-strand conformation polymorphism (SSCP) analysis25 as previously described (information on primers and conditions is available as Supplementary Appendix 1
Supplementary Appendix 1. CACNA1A Primers and Conditions for the Polymerase Chain Reaction (PCR). with the full text of this article at http://www.nejm.org).19 The DNA sequence of conformation variants was determined with the use of a dye-terminator cycle-sequencing kit (Perkin–Elmer, Foster City, Calif.) according to the supplier's instructions. Human messenger RNA (mRNA) sequence X99897 for the α1A subunit of the P/Q-type calcium channel was used as the reference.14 Additional DNA sequencing of CACNA1A — including sequencing in all four repeated domains of the junctions between the third and fourth membrane-spanning segments (S3 and S4); of S4, S5, and S6; and of the P loops — was performed in the probands from Families 16, 18, and 28 and in Patient 3, in whom SSCP analysis did not reveal any abnormal conformer. SSCP analysis was used to test each DNA-sequence variant for its cosegregation with the affected phenotype within families and to determine its frequency in 100 unrelated normal controls.Statistical Analysis
Among subjects with mutations in CACNA1A, Fisher's exact test was used to compare the frequency of symptoms in those who were from families affected by hemiplegic migraine with cerebellar symptoms and in those who were from families affected by pure hemiplegic migraine.26 An overall test for equality of proportions with the extension of Fisher's exact test (the Freeman–Halton method) was used to compare the frequency of symptoms in carriers of the three most frequent mutations associated with hemiplegic migraine with cerebellar symptoms.27 All P values were two-tailed.
Results
Genetic Studies
SSCP analysis showed abnormal conformers in 15 of the 16 probands from families affected by hemiplegic migraine and cerebellar signs, in 4 of the 12 probands from families affected by pure hemiplegic migraine, and in 2 of the 3 subjects with sporadic hemiplegic migraine and cerebellar signs. Sequencing of these conformers revealed nine distinct sequence variants of CACNA1A. All variants were missense mutations that segregated with the disease phenotype within the families of the probands (i.e., all carriers were heterozygous). None of the sequence variants were detected in the 200 chromosomes from the controls. All variants were located in important functional domains of the protein. Therefore, these nine variants were considered to be mutations associated with hemiplegic migraine. Five mutations were novel (R195K, K1336E, R1668W, W1684R, and V1696I), and four have already been described (R583Q, T666M, D715E, and Y1385C) (Table 1Table 1
Mutations in CACNA1A Associated with Familial Hemiplegic Migraine. and Figure 1Figure 1Mutations in CACNA1A Causing Hemiplegic Migraine. and Figure 2Figure 2Pedigrees.).19,20 T666M, the most frequent mutation, was present in Families 1 through 9 and in Patient 1, all of whom were affected by hemiplegic migraine with cerebellar signs. R583Q was detected in three families affected by hemiplegic migraine and cerebellar signs (Families 11, 12, and 14). R1668W was detected in a proband affected by hemiplegic migraine and cerebellar signs (from Family 15) and also in a small family affected by pure hemiplegic migraine (Family 21). All other mutations were each found in a single family. Y1385C was identified in Patient 2 and was shown to be a spontaneous mutation.20 No sequence variant of CACNA1A associated with the disorder was identified in nine probands or in Patient 3, most likely because of the genetic heterogeneity of hemiplegic migraine.
Clinical Spectrum in 117 Subjects with Mutations in CACNA1A
Genotyping of 169 relatives of the 19 probands with identified mutations in CACNA1A detected 96 additional subjects with mutations (Figure 2). A total of 117 subjects with mutations in CACNA1A (58 women and 59 men) were therefore studied, including the 2 subjects with sporadic hemiplegic migraine and cerebellar signs (Patients 1 and 2), 87 members of families affected by hemiplegic migraine and cerebellar signs, and 28 members of families affected by pure hemiplegic migraine. The mean (±SD) age of the 117 people we studied was 37.8±19.1 years (range, 6 to 86).
Phenotype of the 104 Subjects with Mutations and Attacks of Hemiplegic Migraine
Attacks of hemiplegic migraine that fulfilled the criteria of the International Headache Society were reported by 104 of the 117 subjects with mutations (53 women and 51 men, 89 percent), whose mean age was 38±19 years (range, 6 to 86) (Table 1 and Table 2Table 2
Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in CACNA1A.). Most attacks had the typical pattern of migraine with aura, with neurologic symptoms lasting a mean of 60 minutes, followed by headache lasting from 30 minutes to 5 days. However, some prominent features were remarkable. The hemiparesis during the aura, whatever its severity, was never isolated; it was always associated with sensory, language, or visual disturbances (Table 2). Among these disturbances, sensory signs (paresthesias and numbness) were the most frequent (93 percent of subjects), followed by language disturbances such as dysarthria and various degrees of dysphasia (83 percent) and visual symptoms such as scintillating scotoma, phosphenes, hemianopia, and blurred vision (74 percent). A mild degree of confusion or somnolence was occasionally reported (21 percent). Thirty-five percent of the subjects had attacks with bilateral signs, occurring either simultaneously or in succession, and dysphasia occurred irrespective of the side of hemiparesis.There were 66 atypical attacks in 44 of 104 subjects (42 percent). These attacks were characterized either by a prolonged aura lasting up to five days (7 attacks in 6 patients) or by signs of diffuse encephalopathy (59 attacks in 38 patients). Most of the 38 subjects with diffuse encephalopathy were admitted to intensive care units with a suspicion of meningoencephalitis because of confusion or coma, fever (temperature, up to 40°C), severe hemiplegia, and in some patients, seizures (Table 3Table 3
Frequency of Clinical Signs and Symptoms during Severe Attacks with Impairment of Consciousness.). These signs lasted up to six weeks, but the subjects recovered fully. Such severe attacks occurred mostly in younger subjects (mean age, 21±16 years; range, 2 to 83), were the first symptoms of the disease in 21 subjects, were triggered by mild head trauma in 10 subjects, and were triggered by cerebral or coronary angiography in 2 subjects.Attacks of hemiplegic migraine started at a young age in the majority of subjects, with a mean age of onset of 11.7±8.1 years (range, 1 to 51). The natural history was highly variable. The frequency of attacks ranged from one per day to less than five in a subject's lifetime (mean, two or three per year), and long attack-free intervals (range, 2 to 37 years) were reported by 25 subjects. Emotional stress was the most frequent triggering factor, and minor head trauma was the second most frequent. Nine percent of the subjects affected by hemiplegic migraine also reported attacks of migraine with a nonhemiplegic aura, and 23 percent had had attacks of migraine without aura.
Finally, permanent cerebellar signs were found in 62 of the 104 subjects with mutations who had attacks of hemiplegic migraine, all of whom were members of families with cerebellar signs. No subject had permanent motor, sensory, language, or visual symptoms.
Phenotype of the 13 Subjects with Mutations but No Attacks of Hemiplegic Migraine
Thirteen subjects with mutations in CACNA1A had no attacks of hemiplegic migraine. They belonged to six unrelated families and carried six different mutations (Table 1). Their mean age was 36.5±16 years (range, 15 to 65). Two had no symptoms. Five were affected by migraine with nonhemiplegic aura and one by migraine without aura as defined by the criteria of the International Headache Society. One had recurrent headaches with loss of consciousness. Three subjects had single transient episodes of unknown clinical significance that were characterized by dysarthria, unilateral paresthesia, and confusion with fever, respectively. In addition, six of these subjects had permanent neurologic signs (nystagmus and ataxia).
Characteristics of Permanent Neurologic Signs
Neurologic examination was performed in 105 of the 117 subjects with mutations. Permanent neurologic signs were observed in 68 subjects, 62 of whom also had attacks of hemiplegic migraine; they included Patients 1 and 2 and 66 members of families affected by hemiplegic migraine with cerebellar signs (Table 1 and Table 2). The most frequent sign was nystagmus, which was observed in 47 subjects. Gait ataxia was the second most frequent sign (in 36 subjects) and was associated with limb ataxia in 27 subjects, nystagmus in 19, and dysarthria in 9 (Figure 2). The mean age of subjects with permanent neurologic signs was 40±18 years (range, 11 to 78). Six subjects with ataxia never had any attacks of hemiplegic migraine; two of these subjects, who were 18 and 61 years of age, had isolated ataxia without any history of migraine. The severity of ataxia increased with age and caused gait impairment in all nine affected subjects who were over 50 years of age, but none required a wheelchair. The frequency of severe attacks was similar in subjects with and without ataxia who shared a given mutation (1.51 vs. 1.50 per year). Finally, early-onset postural tremor was present in six subjects from Family 10 (Figure 2). This tremor affected both hands but not the head or the voice.
Correlations between Genotype and Phenotype
Mutations identified in families affected by hemiplegic migraine with cerebellar signs and in subjects with sporadic hemiplegic migraine with permanent cerebellar signs were recurrent and, with the exception of R1668W, were distinct from those identified in families affected by pure hemiplegic migraine. Six mutations (R583Q, T666M, D715E, Y1385C, R1668W, and W1684R) were found in families affected by hemiplegic migraine with cerebellar signs and in subjects with sporadic cases of hemiplegic migraine with cerebellar signs; 83 percent of the subjects examined who had these mutations had nystagmus, ataxia, or both. In contrast, the results of neurologic examination were normal for all the subjects examined who had R195K, K1336E, or V1696I mutations. The person who had K1336E but was not examined reported having no disability when interviewed by telephone. R1668W was found in the proband of Family 15, who was affected by hemiplegic migraine with ataxia, and also in Family 21, a small family with three subjects who were affected by pure hemiplegic migraine.
In our analyses of the 117 subjects with mutations, we first compared the frequency of symptoms in the 89 subjects from families affected by hemiplegic migraine with cerebellar signs (we included the 2 patients with sporadic hemiplegic migraine) with the frequency in the 28 subjects from families affected by pure hemiplegic migraine (Table 2). The frequency of atypical attacks and the frequency of severe first attacks were higher in subjects with mutations who were from families affected by hemiplegic migraine with cerebellar signs than in subjects with mutations who were from families affected by pure hemiplegic migraine (49 percent vs. 21 percent for atypical attacks, P=0.02; 26 percent vs. 0 percent for severe first attacks, P=0.003).
In a second step, we searched for correlations between genotype and phenotype by comparing the frequency of symptoms among the 85 subjects with the three most frequent mutations linked to hemiplegic migraine with cerebellar signs, R583Q, T666M, and D715E (Table 4Table 4
Comparison of the Frequency of Symptoms in Subjects with the Three Most Common Mutations Associated with Hemiplegic Migraine with Cerebellar Signs.). The phenotype in those with T666M was characterized by the highest frequency of hemiplegic migraine (98 percent), severe attacks with coma (50 percent), and nystagmus (86 percent). The phenotype in those with R583Q was characterized by the highest frequency of ataxia (81 percent) in the absence of any nystagmus. The phenotype in those with D715E was characterized by the lowest frequency of attacks of hemiplegic migraine (64 percent).Discussion
We characterized the clinical features of familial hemiplegic migraine in 117 subjects with nine distinct mutations in CACNA1A. Familial hemiplegic migraine is an unusual inherited variety of migraine with aura characterized by an autosomal dominant pattern of transmission and the presence of unilateral motor deficits during the aura. In addition to these well-known features, there are other interesting clinical characteristics of familial hemiplegic migraine. The hemiparesis during the aura is always associated with sensory, language, or visual symptoms. However, one fourth of the patients affected by familial hemiplegic migraine do not have visual symptoms, whereas in more common varieties of migraine with aura, visual symptoms are almost universal (occurring in close to 99 percent of patients).28 Bilateral motor signs are observed in one third of patients affected by hemiplegic migraine but very rarely in patients affected by the other varieties of migraine with aura.28 Severe attacks with impairment of consciousness occur in one third of patients with hemiplegic migraine, with full recovery. Such attacks may lead to major difficulties in diagnosis, as in two subjects from our series in whom recurrent coma with hemiplegia that lasted for weeks and seizures were the dominant pattern of presentation. Finally, permanent cerebellar ataxia, nystagmus, or both are found in about 80 percent of subjects with mutations who are from families with hemiplegic migraine and cerebellar signs.
The five novel mutations in CACNA1A that we identified are all missense mutations, as are the eight previously known mutations. All these mutations are located in important functional domains of the calcium channel: the voltage sensor, the pore, and the pore-lining loops.14,19-23 Other autosomal dominant neurologic disorders have been associated with distinct types of mutations in CACNA1A. Episodic ataxia type 2, which is characterized by attacks of paroxysmal ataxia, is mostly associated with truncations of the gene,14,29,30 and spinocerebellar ataxia type 6, a late-onset progressive ataxia, is associated with CAG-repeat expansions.31,32
Our data strongly suggest that pure familial hemiplegic migraine and familial hemiplegic migraine with cerebellar signs, which were previously considered to be two clinical subtypes, are associated with distinct mutations in CACNA1A.14,19-23 The presence of R1668W in two families, one without and the other with cerebellar signs, could be the result of a clinical misclassification due to the low number of examined subjects or a low penetrance of cerebellar signs in subjects with R1668W. If confirmed in larger samples, these correlations between genotype and phenotype may provide clues about the mechanisms leading to cerebellar dysfunction in people with mutations in CACNA1A.
When we examined familial hemiplegic migraine with cerebellar signs, we found that subjects with T666M had the highest penetrance of hemiplegic migraine (98 percent), severe attacks with coma (50 percent), and nystagmus (86 percent). Subjects with R583Q had the highest penetrance of gait ataxia (81 percent) in the absence of any nystagmus. Subjects with D715E had the lowest penetrance of attacks of hemiplegic migraine (64 percent); tremor was found in some subjects with D715E. The association of hemiplegic migraine with nystagmus and tremor was previously described in another family, without a molecular analysis.33 Tremor may be part of the clinical spectrum induced by mutations in CACNA1A; however, the current data are insufficient to prove this hypothesis.
In conclusion, hemiplegic migraine caused by mutations in CACNA1A, a gene that encodes a neuronal calcium channel, has a broad clinical spectrum, including paroxysmal attacks and permanent signs, both of which have a highly variable severity. The variability of the mutations in CACNA1A partly accounts for this variability in disease severity. In vitro electrophysiological studies have compared P/Q-type calcium currents in cells expressing wild-type and mutant CACNA1A. Seven mutations linked to familial hemiplegic migraine, including R583Q, T666M, and D715E, have been shown to modify both the density and the gating properties of functional channels.34-36 When in vitro models were used, no clear difference was found between mutations associated with hemiplegic migraine with and without cerebellar signs. However, these studies probably do not reproduce the complexity of the situation in vivo. In addition, the clinical variability among subjects with the same mutation suggests that other genetic or environmental factors also influence the expression of these phenotypes. Finally, screening for missense mutations in CACNA1A may be useful in the diagnosis of disease in patients with recurrent coma with hemiplegia or in patients with sporadic hemiplegic migraine.
Supported in part by grants from INSERM and the Assistance Publique–Hôpitaux de Paris (project A0B94005). Dr. Ducros is the recipient of a fellowship from INSERM, and Dr. Denier is the recipient of a fellowship from the Fondation pour la Recherche Médicale.
We are indebted to the families for their participation and to Drs. M.A. Barthez, C. Billard, F. Chedru, P. Despres, D. Guerouaou, E. Hirsch, J. Julien, G. Lucotte, M. Madigand, A. Michel, J.P. Misson, T. Moulin, G. Ponsot, B. Romain, and F. Tison for referring patients to us.
Source Information
From INSERM E99-21, Faculté de Médecine Lariboisière, Paris (A.D., C.D., A.J., M.C., C.L., E.T.-L.); the Département de Neurologie (A.D., K.V., M.-G.B.) and Laboratoire de Génétique (A.J., M.C., E.T.-L.), Hôpital Lariboisière, Paris; the Département de Neurologie, Centre Hospitalier Universitaire, Rennes, France (F.D.); and the Laboratoire de Biophysique, Hôpital Fernand Widal, Paris (E.V.).
Address reprint requests to Dr. Ducros at the Department of Neurology, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris CEDEX 10, France, or at anne.ducros@lrb.ap-hop-paris.fr.
- References
References
1
Headache Classification Committee of the International Headache Society
CrossRef | Web of Science | Medline2
Stewart WF ,Lipton RB ,Celentano DD ,Reed ML . Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-69
CrossRef | Web of Science | Medline3
Henry P ,Michel P ,Dartigues JF ,Tison F ,Vivares C . Epidémiologie de la maladie migraineuse. Circ Metab Cerv 1990;7:229-2364
Lance JW. Mechanism and management of headache. 4th ed. London: Butterworth Scientific, 1982.
5
Ulrich V ,Gervil M ,Kyvik KO ,Olesen J ,Russell MB . Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol 1999;45:242-246
CrossRef | Web of Science | Medline6
Gervil M ,Ulrich V ,Kaprio J ,Olesen J ,Russell MB . The relative role of genetic and environmental factors in migraine without aura. Neurology 1999;53:995-999
Web of Science | Medline7
Clarke JM . On recurrent motor paralysis in migraine: with report of a family in which recurrent hemiplegia accompanied the attacks. BMJ 1910;1:1534-1538
CrossRef | Medline8
Whitty CWM . Familial hemiplegic migraine. J Neurol Neurosurg Psychiatry 1953;16:172-177
CrossRef | Web of Science | Medline9
Blau JN ,Whitty CWM . Familial hemiplegic migraine. Lancet 1955;2:1115-1116
CrossRef | Web of Science10
Fitzsimons RB ,Wolfenden WH . Migraine coma: meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain 1985;108:555-577
CrossRef | Web of Science | Medline11
Ohta M ,Araki S ,Kuroiwa Y . Familial occurrence of migraine with a hemiplegic syndrome and cerebellar manifestations. Neurology 1967;17:813-817
Web of Science | Medline12
Joutel A ,Bousser MG ,Biousse V , et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5:40-45
CrossRef | Web of Science | Medline13
Joutel A ,Ducros A ,Vahedi K , et al. Genetic heterogeneity of familial hemiplegic migraine. Am J Hum Genet 1994;55:1166-1172
Web of Science | Medline14
Ophoff RA ,Terwindt GM ,Vergouwe MN , et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552
CrossRef | Web of Science | Medline15
Elliott MA ,Peroutka SJ ,Welch S ,May EF . Familial hemiplegic migraine, nystagmus, and cerebellar atrophy. Ann Neurol 1996;39:100-106
CrossRef | Web of Science | Medline16
Terwindt GM ,Ophoff RA ,Haan J , et al. Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Neurology 1998;50:1105-1110
Web of Science | Medline17
Ophoff RA ,van Eijk R ,Sandkuijl LA , et al. Genetic heterogeneity of familial hemiplegic migraine. Genomics 1994;22:21-26
CrossRef | Web of Science | Medline18
Ducros A ,Joutel A ,Vahedi K , et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol 1997;42:885-890
CrossRef | Web of Science | Medline19
Ducros A ,Denier C ,Joutel A , et al. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia. Am J Hum Genet 1999;64:89-98
CrossRef | Web of Science | Medline20
Vahedi K ,Denier C ,Ducros A , et al. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology 2000;55:1040-1042
Web of Science | Medline21
Battistini S ,Stenirri S ,Piatti M , et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 1999;53:38-43
Web of Science | Medline22
Friend KL ,Crimmins D ,Phan TG , et al. Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM. Hum Genet 1999;105:261-265
CrossRef | Web of Science | Medline23
Carrera P ,Piatti M ,Stenirri S , et al. Genetic heterogeneity in Italian families with familial hemiplegic migraine. Neurology 1999;53:26-33
Web of Science | Medline24
Gardner K ,Barmada MM ,Ptacek LJ ,Hoffman EP . A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology 1997;49:1231-1238
Web of Science | Medline25
Orita M ,Iwahana H ,Kanazawa H ,Hayashi K ,Sekiya T . Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989;86:2766-2770
CrossRef | Web of Science | Medline26
Hollander M, Wolfe DA. Non-parametric statistical methods. New York: John Wiley, 1973.
27
Freeman GH ,Halton JH . Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951;38:141-149
Web of Science | Medline28
Russell MB ,Olesen J . A nosographic analysis of the migraine aura in a general population. Brain 1996;119:355-361
CrossRef | Web of Science | Medline29
Yue Q ,Jen JC ,Thwe MM ,Nelson SF ,Baloh RW . De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. Am J Med Genet 1998;77:298-301
CrossRef | Web of Science | Medline30
Denier C ,Ducros A ,Vahedi K , et al. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 1999;52:1816-1821
Web of Science | Medline31
Zhuchenko O ,Bailey J ,Bonnen P , et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997;15:62-69
CrossRef | Web of Science | Medline32
Geschwind DH ,Perlman S ,Figueroa KP ,Karrim J ,Baloh RW ,Pulst SM . Spinocerebellar ataxia type 6: frequency of the mutation and genotype-phenotype correlations. Neurology 1997;49:1247-1251
Web of Science | Medline33
Zifkin B ,Andermann E ,Andermann F ,Kirkham T . An autosomal dominant syndrome of hemiplegic migraine, nystagmus, and tremor. Ann Neurol 1980;8:329-332
CrossRef | Web of Science | Medline34
Kraus RL ,Sinnegger MJ ,Glossmann H ,Hering S ,Striessnig J . Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem 1998;273:5586-5590
CrossRef | Web of Science | Medline35
Hans M ,Luvisetto S ,Williams ME , et al. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci 1999;19:1610-1619
Web of Science | Medline36
Kraus RL ,Sinnegger MJ ,Koschak A , et al. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem 2000;275:9239-9243
CrossRef | Web of Science | Medline
- Citing Articles (170)
Citing Articles
1
Sanjeev Rajakulendran, Diego Kaski, Michael G. Hanna. (2012) Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nature Reviews Neurology
CrossRef2
Robert W. Baloh. 2012. Episodic ataxias 1 and 2. , 595-602.
CrossRef3
Ning Luo, Wei Di, Aiwu Zhang, Ying Wang, Minghui Ding, Weiwei Qi, Yingting Zhu, Mark W. Massing, Yannan Fang. (2012) A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis. Pain Medicine 13:1, 80-86
CrossRef4
Osvaldo D. Uchitel, Carlota González Inchauspe, Francisco J. Urbano, Mariano N. Di Guilmi. (2011) CaV2.1 voltage activated calcium channels and synaptic transmission in familial hemiplegic migraine pathogenesis. Journal of Physiology-Paris
CrossRef5
Sawako Yamazaki, Kanju Ikeno, Tokinari Abe, Jun Tohyama, Yoshiki Adachi. (2011) Hemiconvulsion-Hemiplegia-Epilepsy Syndrome Associated With CACNA1A S218L Mutation. Pediatric Neurology 45:3, 193-196
CrossRef6
Reinald Shyti, Boukje de Vries, Arn van den Maagdenberg. (2011) Migraine Genes and the Relation to Gender. Headache: The Journal of Head and Face Pain 51:6, 880-890
CrossRef7
Michael Bjørn Russell, Anne Ducros. (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. The Lancet Neurology 10:5, 457-470
CrossRef8
Jennie Taylor, Howard P. Goodkin. (2011) Dizziness and Vertigo in the Adolescent. Otolaryngologic Clinics of North America 44:2, 309-321
CrossRef9
Jakob M. Hansen, Lise L. Thomsen, Jes Olesen, Messoud Ashina. (2011) Calcitonin Gene-Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine. Headache: The Journal of Head and Face Pain 51:4, 544-553
CrossRef10
Taku Omata, Jun-ichi Takanashi, Takahito Wada, Hidee Arai, Yuzo Tanabe. (2011) Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain and Development 33:4, 332-334
CrossRef11
Aynur Özge, Cristiano Termine, Fabio Antonaci, Sophia Natriashvili, Vincenzo Guidetti, Çiçek Wöber-Bingöl. (2011) Overview of diagnosis and management of paediatric headache. Part I: diagnosis. The Journal of Headache and Pain 12:1, 13-23
CrossRef12
Harsha Bhatia, Fawzi Babtain. (2011) Sporadic Hemiplegic Migraine with Seizures and Transient MRI Abnormalities. Case Reports in Neurological Medicine 2011, 1-4
CrossRef13
T. Freilinger, N. Ackl, A. Ebert, C. Schmidt, B. Rautenstrauss, M. Dichgans, A. Danek. (2011) A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. Journal of the Neurological Sciences 300:1-2, 160-163
CrossRef14
Hans C. Diener, Tobias Kurth. 2011. Migraine and Stroke. , 720-733.
CrossRef15
Katalin Sas, Árpád Párdutz, József Toldi, László Vécsei. (2010) Dementia, stroke and migraine — Some common pathological mechanisms. Journal of the Neurological Sciences 299:1-2, 55-65
CrossRef16
P. J. Adams, R. L. Rungta, E. Garcia, A. M. J. M. van den Maagdenberg, B. A. MacVicar, T. P. Snutch. (2010) Contribution of calcium-dependent facilitation to synaptic plasticity revealed by migraine mutations in the P/Q-type calcium channel. Proceedings of the National Academy of Sciences 107:43, 18694-18699
CrossRef17
Dipa L Raja Rayan, Michael G Hanna. 2010. Ion Channels and Human Disorders. .
CrossRef18
M. Suzuki, W. Van Paesschen, I. Stalmans, S. Horita, H. Yamada, B. A. Bergmans, E. Legius, F. Riant, P. De Jonghe, Y. Li, T. Sekine, T. Igarashi, I. Fujimoto, K. Mikoshiba, M. Shimadzu, M. Shiohara, N. Braverman, L. Al-Gazali, T. Fujita, G. Seki. (2010) Defective membrane expression of the Na+-HCO3- cotransporter NBCe1 is associated with familial migraine. Proceedings of the National Academy of Sciences 107:36, 15963-15968
CrossRef19
Ozge Yilmaz-Kusbeci, Nuket Gocmen-Mas, Aylin Yucel, Hamit S. Karabekir, Tolga Ertekin, Ayse C. Yazici. (2010) Evaluation of Cerebellar and Cerebral Volume in Migraine with Aura: A Stereological Study. The Cerebellum 9:3, 345-351
CrossRef20
A. Ducros. (2010) Génétique de la migraine. Douleur et Analgésie 23:3, 133-139
CrossRef21
Oleg I. Klychnikov, Ka Wan Li, Igor A. Sidorov, Maarten Loos, Sabine Spijker, Ludo A. M. Broos, Rune R. Frants, Michel D. Ferrari, Oleg A. Mayboroda, André M. Deelder, August B. Smit, Arn M. J. M. van den Maagdenberg. (2010) Quantitative cortical synapse proteomics of a transgenic migraine mouse model with mutated CaV2.1 calcium channels. PROTEOMICS 10:13, 2531-2535
CrossRef22
Gerald W. Zamponi, Philippe Lory, Edward Perez-Reyes. (2010) Role of voltage-gated calcium channels in epilepsy. Pflügers Archiv - European Journal of Physiology 460:2, 395-403
CrossRef23
Daniela Pietrobon. (2010) CaV2.1 channelopathies. Pflügers Archiv - European Journal of Physiology 460:2, 375-393
CrossRef24
Elfriede Karner, Margarete Delazer, Thomas Benke, Sylvia Bösch. (2010) Cognitive Functions, Emotional Behavior, and Quality of Life in Familial Hemiplegic Migraine. Cognitive and Behavioral Neurology 23:2, 106-111
CrossRef25
Dimitri M. Kullmann. (2010) Neurological Channelopathies. Annual Review of Neuroscience 33:1, 151-172
CrossRef26
Thomas Wieser, Julio Pascual, Agusto Oterino, Michael Soso, Michael Barmada, Kathy L. Gardner. (2010) A Novel Locus for Familial Migraine on Xp22. Headache: The Journal of Head and Face Pain 50:6, 955-962
CrossRef27
Elide Mantuano, Silvia Romano, Liana Veneziano, Cinzia Gellera, Barbara Castellotti, Sara Caimi, Daniela Testa, Margherita Estienne, Giovanna Zorzi, Marianna Bugiani, Yusuf A. Rajabally, Maria J Garcìa Barcina, Serena Servidei, Aurora Panico, Marina Frontali, Caterina Mariotti. (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. Journal of the Neurological Sciences 291:1-2, 30-36
CrossRef28
Michael Bjørn Russell. (2010) Management of sporadic and familial hemiplegic migraine. Expert Review of Neurotherapeutics 10:3, 381-387
CrossRef29
Michael G. Harrington, Alfred N. Fonteh, Xianghong Arakaki, Robert P. Cowan, Laurel E. Ecke, Hailey Foster, Andreas F. Hühmer, Roger G. Biringer. (2010) Capillary Endothelial Na + , K + , ATPase Transporter Homeostasis and a New Theory for Migraine Pathophysiology. Headache: The Journal of Head and Face Pain 50:3, 459-478
CrossRef30
Andro Zangaladze, Ali A. Asadi-Pooya, Avi Ashkenazi, Michael R Sperling. (2010) Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation. Epilepsy & Behavior 17:2, 293-295
CrossRef31
S. A. Serra, E. Cuenca-Leon, A. Llobet, F. Rubio-Moscardo, C. Plata, O. Carreno, N. Fernandez-Castillo, R. Corominas, M. A. Valverde, A. Macaya, B. Cormand, J. M. Fernandez-Fernandez. (2010) A mutation in the first intracellular loop of CACNA1A prevents P/Q channel modulation by SNARE proteins and lowers exocytosis. Proceedings of the National Academy of Sciences 107:4, 1672-1677
CrossRef32
Arn M. J. M. van den Maagdenberg, Tommaso Pizzorusso, Simon Kaja, Nicole Terpolilli, Maryna Shapovalova, Freek E. Hoebeek, Curtis F. Barrett, Lisa Gherardini, Rob C. G. van de Ven, Boyan Todorov, Ludo A. M. Broos, Angelita Tottene, Zhenyu Gao, Mariann Fodor, Chris I. De Zeeuw, Rune R. Frants, Nikolaus Plesnila, Jaap J. Plomp, Daniela Pietrobon, Michel D. Ferrari. (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Ca v 2.1 S218L mice. Annals of Neurology 67:1, 85-98
CrossRef33
Hitoshi Sejima, Tsutomu Miura, Mariko Abe, Jun Mine, Takeshi Kasai, Kazuko Kishi, Yasuhisa Kajino, Seiji Yamaguchi. (2010) A Girl with Panayiotopoulos Syndrome Associated with Sporadic Hemiplegic Migraine: A Case Report. Journal of the Japan Epilepsy Society 27:3, 363-368
CrossRef34
S Debiais, C Hommet, I Bonnaud, MA Barthez, S Rimbaux, F Riant, A Autret. (2009) The FHM1 mutation S218L: a severe clinical phenotype? A case report and review of the literature. Cephalalgia 29:12, 1337-1339
CrossRef35
Susan E. Tomlinson, Michael G. Hanna, Dimitri M. Kullmann, S. Veronica Tan, David Burke. (2009) Clinical neurophysiology of the episodic ataxias: Insights into ion channel dysfunction in vivo. Clinical Neurophysiology 120:10, 1768-1776
CrossRef36
C Cleves, S Parikh, AD Rothner, SJ Tepper. (2009) Link between confusional migraine, hemiplegic migraine and episodic ataxia type 2: hypothesis, family genealogy, gene typing and classification. Cephalalgia
CrossRef37
Ester Cuenca-León, Roser Corominas, Magda Montfort, Josep Artigas, Manuel Roig, Mònica Bayés, Bru Cormand, Alfons Macaya. (2009) Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred. neurogenetics 10:3, 191-198
CrossRef38
Boukje Vries, Rune R. Frants, Michel D. Ferrari, Arn M. J. M. Maagdenberg. (2009) Molecular genetics of migraine. Human Genetics 126:1, 115-132
CrossRef39
Roser Corominas, Marta Ribasés, Ester Cuenca-León, Bernat Narberhaus, Selma A. Serra, Mireia del Toro, Manuel Roig, José M. Fernández-Fernández, Alfons Macaya, Bru Cormand. (2009) Contribution of syntaxin 1A to the genetic susceptibility to migraine: A case–control association study in the Spanish population. Neuroscience Letters 455:2, 105-109
CrossRef40
Peter J. Goadsby. (2009) Pathophysiology of Migraine. Neurologic Clinics 27:2, 335-360
CrossRef41
Joanna C. Jen, Robert W. Baloh. (2009) Familial Episodic Ataxia. Annals of the New York Academy of Sciences 1164:1, 252-256
CrossRef42
M-J Castro, AH Stam, C Lemos, B de Vries, KRJ Vanmolkot, J Barros, GM Terwindt, RR Frants, J Sequeiros, MD Ferrari, JM Pereira-Monteiro, AMJM van den Maagdenberg. (2009) First mutation in the voltage-gated Na V 1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. Cephalalgia 29:3, 308-313
CrossRef43
Anthony R Hart, Ruth Trinick, Daniel J Connolly, Santosh R Mordekar. (2009) Profound encephalopathy with complete recovery in three children with familial hemiplegic migraine. Journal of Paediatrics and Child Health 45:3, 154-157
CrossRef44
Liana Veneziano, Serena Guida, Elide Mantuano, Paola Bernard, Patrizia Tarantino, Loredana Boccone, Fuki M. Hisama, Paola Carrera, Carla Jodice, Marina Frontali. (2009) Newly characterised 5′ and 3′ regions of CACNA1A gene harbour mutations associated with Familial Hemiplegic Migraine and Episodic Ataxia. Journal of the Neurological Sciences 276:1-2, 31-37
CrossRef45
Yukio Iwanaka, Kazumasa Okada, Naoki Akamatsu, Takenori Uozumi, Yoshiki Adachi, Sadatoshi Tsuji. (2009) A case of sporadic hemiplegic migraine with cerebellar ataxia. Rinsho Shinkeigaku 49:5, 267-270
CrossRef46
Anne Ducros, Dominique Valade. 2009. Génétique des céphalées. , 45-56.
CrossRef47
Katharina Eikermann-Haerter, Ergin Dileköz, Chiho Kudo, Sean I. Savitz, Christian Waeber, Michael J. Baum, Michel D. Ferrari, Arn M.J.M. van den Maagdenberg, Michael A. Moskowitz, Cenk Ayata. (2008) Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. Journal of Clinical Investigation
CrossRef48
Ryan M. Hung, Daune L. MacGregor. (2008) Management of pediatric migraine: Current concepts and controversies. The Indian Journal of Pediatrics 75:11, 1139-1148
CrossRef49
AH Stam, KRJ Vanmolkot, HPH Kremer, J Gärtner, J Brown, E Leshinsky-Silver, R Gilad, EE Kors, WS Frankhuizen, HB Ginjaar, J Haan, RR Frants, MD Ferrari, AMJM Van Den Maagdenberg, GM Terwindt. (2008) CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clinical Genetics 74:5, 481-485
CrossRef50
Joanna C. Jen. (2008) Hereditary Episodic Ataxias. Annals of the New York Academy of Sciences 1142:1, 250-253
CrossRef51
Andrea Gallanti, Alessandra Tonelli, Veronica Cardin, Gennaro Bussone, Nereo Bresolin, Maria Teresa Bassi. (2008) A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures. Journal of the Neurological Sciences 273:1-2, 123-126
CrossRef52
A. Roubertie, B. Echenne, J. Leydet, S. Soete, B. Krams, F. Rivier, F. Riant, E. Tournier-Lasserve. (2008) Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. Journal of Neurology 255:10, 1600-1602
CrossRef53
E Cuenca-León, R Corominas, N Fernàndez-Castillo, V Volpini, M del Toro, M Roig, A Macaya, B Cormand. (2008) Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes. Cephalalgia 28:10, 1039-1047
CrossRef54
Ichiro Yabe, Mayumi Kitagawa, Yashio Suzuki, Keishi Fujiwara, Takahito Wada, Takashi Tsubuku, Norihito Takeichi, Ken Sakushima, Hiroyuki Soma, Sachiko Tsuji, Masaaki Niino, Shinji Saitoh, Hidenao Sasaki. (2008) Downbeat positioning nystagmus is a common clinical feature despite variable phenotypes in an FHM1 family. Journal of Neurology 255:10, 1541-1544
CrossRef55
LL Thomsen, E Oestergaard, A Bjornsson, H Stefansson, AC Fasquel, J Gulcher, K Stefansson, J Olesen. (2008) Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia 28:9, 914-921
CrossRef56
Pasquale Montagna. (2008) Migraine genetics. Expert Review of Neurotherapeutics 8:9, 1321-1330
CrossRef57
Elisabetta Del Zotto, Alessandro Pezzini, Alessia Giossi, Irene Volonghi, Alessandro Padovani. (2008) Migraine and ischemic stroke: a debated question. Journal of Cerebral Blood Flow & Metabolism 28:8, 1399-1421
CrossRef58
Yee-Cheun Chan, Jean-Marc Burgunder, Einar Wilder-Smith, Soh-Eng Chew, Karen M.J. Lam-Mok-Sing, Vijay Sharma, Benjamin K.C. Ong. (2008) Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation. Journal of Clinical Neuroscience 15:8, 891-894
CrossRef59
B de Vries, AH Stam, F Beker, AMJM van den Maagdenberg, KRJ Vanmolkot, LAEM Laan, IB Ginjaar, RR Frants, H Lauffer, J Haan, JP Haas, GM Terwindt, MD Ferrari. (2008) CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood. Cephalalgia 28:8, 887-891
CrossRef60
A Lebas, L Guyant-Maréchal, D Hannequin, F Riant, E Tournier-Lasserve, D Parain. (2008) Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia 28:7, 774-777
CrossRef61
Jesse Weinberger. (2008) Stroke and migraine. Current Treatment Options in Cardiovascular Medicine 10:3, 253-260
CrossRef62
C. J. Cook, D. Jones. (2008) Hemiplegic migraine associated with interscalene block and general anaesthesia. Anaesthesia 63:6, 678-679
CrossRef63
JM Hansen, LL Thomsen, J Olesen, M Ashina. (2008) Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide. Cephalalgia 28:5, 496-505
CrossRef64
Donald R. Nixdorf, Ana M. Velly, Aurelio A. Alonso. (2008) Neurovascular Pains: Implications of Migraine for the Oral and Maxillofacial Surgeon. Oral and Maxillofacial Surgery Clinics of North America 20:2, 221-235
CrossRef65
T Freilinger, M Bohe, B Wegener, B Müller-Myhsok, M Dichgans, H Knoblauch. (2008) Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia 28:4, 403-407
CrossRef66
Liesbet Deprez, Sarah Weckhuysen, Katelijne Peeters, Tine Deconinck, Kristl G. Claeys, Lieve R.F. Claes, Arvid Suls, Tine Van Dyck, Andr Palmini, Gert Matthijs, Wim Van Paesschen, Peter De Jonghe. (2008) Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia 49:3, 500-508
CrossRef67
James T.H. Teo, Susanne A. Schneider, Binith J. Cheeran, Miguel Fernandez-del-Olmo, Paola Giunti, John C. Rothwell, Kailash P. Bhatia. (2008) Prolonged cortical silent period but normal sensorimotor plasticity in spinocerebellar ataxia 6. Movement Disorders 23:3, 378-385
CrossRef68
Joanna C Jen. (2008) Recent advances in the genetics of recurrent vertigo and vestibulopathy. Current Opinion in Neurology 21:1, 3-7
CrossRef69
Stephen D. Silberstein. 2008. Outcomes, Efficacy, and Complications of Headache Management. , 1261-1279.
CrossRef70
M-J Castro, B Nunes, B De Vries, C Lemos, KRJ Vanmolkot, JJMW Van Den Heuvel, T Temudo, J Barros, J Sequeiros, RR Frants, JB Koenderink, JM Pereira-Monteiro, AMJM Van Den Maagdenberg. (2008) Two novel functional mutations in the Na+,K+-ATPase α2-subunit ATP1A2 gene in patients with familial hemiplegic migraine and associated neurological phenotypes. Clinical Genetics 73:1, 37-43
CrossRef71
Maria-José Castro, Anine H. Stam, Carolina Lemos, José Barros, Raquel G. Gouveia, Isabel Pavão Martins, Jan B. Koenderink, Kaate R. J. Vanmolkot, Alexandre P. Mendes, Rune R. Frants, Michel D. Ferrari, Jorge Sequeiros, José M. Pereira-Monteiro, Arn M. J. M. Maagdenberg. (2007) Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine. Journal of Human Genetics 52:12, 990-998
CrossRef72
T. J. Kleinig, T. Kimber, P. D. Thompson. (2007) Acute encephalopathy as the initial symptom of CADASIL. Internal Medicine Journal 37:11, 786-787
CrossRef73
G. Xie, S. J. Clapcote, B. J. Nieman, T. Tallerico, Y. Huang, I. Vukobradovic, S. P. Cordes, L. R. Osborne, J. Rossant, J. G. Sled, J. T. Henderson, J. C. Roder. (2007) Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes, Brain and Behavior 6:8, 717-727
CrossRef74
Y-H Cha, D Millett, M Kane, J Jen, R Baloh. (2007) Adult-onset hemiplegic migraine with cortical enhancement and oedema. Cephalalgia 27:10, 1166-1170
CrossRef75
J. Willson, S. Kapur. (2007) Apnoeic spells following general anaesthesia in a patient with familial hemiplegic migraine. Anaesthesia 62:9, 956-958
CrossRef76
Kaate R J Vanmolkot, Anine H Stam, Ashok Raman, Jan B Koenderink, Boukje de Vries, Eelke H van den Boogerd, Judith van Vark, Jeroen J M W van den Heuvel, Nin Bajaj, Gisela M Terwindt, Joost Haan, Rune R Frants, Michel D Ferrari, Arn M J M van den Maagdenberg. (2007) First case of compound heterozygosity in Na,K-ATPase gene ATP1A2 in familial hemiplegic migraine. European Journal of Human Genetics 15:8, 884-888
CrossRef77
Azlisham Mohd Nor, Gary A Ford. (2007) Misdiagnosis of stroke. Expert Review of Neurotherapeutics 7:8, 989-1001
CrossRef78
Scott D. Z. Eggers. (2007) Migraine-related vertigo: Diagnosis and treatment. Current Pain and Headache Reports 11:3, 217-226
CrossRef79
Desiree M. Fernandez, Collette K. Hand, Brian J. Sweeney, Nollaig A. Parfrey. (2007) A Novel ATP1A2 Gene Mutation in an Irish Familial Hemiplegic Migraine Kindred. Headache: The Journal of Head and Face Pain 0:0, 070623002213004-???
CrossRef80
Maurice Vincent, Nouchine Hadjikhani. (2007) The Cerebellum and Migraine. Headache: The Journal of Head and Face Pain 47:6, 820-833
CrossRef81
Maija Wessman, Gisela M Terwindt, Mari A Kaunisto, Aarno Palotie, Roel A Ophoff. (2007) Migraine: a complex genetic disorder. The Lancet Neurology 6:6, 521-532
CrossRef82
Daniela Pietrobon. (2007) Familial hemiplegic migraine. Neurotherapeutics 4:2, 274-284
CrossRef83
Sanjeev Rajakulendran, Stephanie Schorge, Dimitri M. Kullmann, Michael G. Hanna. (2007) Episodic ataxia type 1: A neuronal potassium channelopathy. Neurotherapeutics 4:2, 258-266
CrossRef84
Christian Waeber. (2007) Targeting neuronal hyperexcitability for antimigraine drug development. Future Neurology 2:2, 179-188
CrossRef85
Jesse Weinberger. (2007) Stroke and migraine. Current Cardiology Reports 9:1, 13-19
CrossRef86
Stephen D. Silberstein, William B. Young. 2007. Headache and Facial Pain. , 1245-1266.
CrossRef87
M.T. Andrés del Barrio, M.J. Sánchez Palomo, C. Serrano González, A. Yusta Izquierdo. (2007) Migraña. Medicine - Programa de Formación Médica Continuada Acreditado 9:70, 4480-4487
CrossRef88
Jesse Weinberger. (2006) Interactions between migraine and stroke. Current Treatment Options in Neurology 8:6, 513-517
CrossRef89
2006. Migraine Prophylaxis. .
CrossRef90
T. Freilinger, M. Dichgans. (2006) Genetik der Migräne. Der Nervenarzt 77:10, 1186-1195
CrossRef91
Pasquale Montagna, Mirella Mochi. 2006. Migraine: Genetics. .
CrossRef92
J. Jay Gargus. 2006. Receptor, Transporter and Ion Channel Diseases. .
CrossRef93
Nicola Specchio, Federico Vigevano. (2006) The spectrum of benign infantile seizures. Epilepsy Research 70, 156-167
CrossRef94
Esther de Theije-Kors, Joost Haan. (2006) Hemiplegic and Basilar-type Migraine: Epidemiology, Genetics, and Mechanisms. Headache Currents 3:4, 73-81
CrossRef95
Gisela M. Terwindt, Joost Haan, Michel D. Ferrari. (2006) Hemiplegic and Basilar-type Migraine: Current and Future Treatment. Headache Currents 3:4, 97-100
CrossRef96
Boukje De Vries, Joost Haan, Rune R. Frants, Arn M.J.M. Van den Maagdenberg, Michel D. Ferrari. (2006) Genetic Biomarkers for Migraine. Headache: The Journal of Head and Face Pain 46:7, 1059-1068
CrossRef97
Michael G. Harrington, Alfred N. Fonteh, Robert P. Cowan, Kathy Perrine, Janice M. Pogoda, Roger G. Biringer, Andreas F.R. Huhmer. (2006) Cerebrospinal Fluid Sodium Increases in Migraine. Headache: The Journal of Head and Face Pain 46:7, 1128-1135
CrossRef98
J. Jay Gargus. (2006) Ion Channel Functional Candidate Genes in Multigenic Neuropsychiatric Disease. Biological Psychiatry 60:2, 177-185
CrossRef99
Anne Ducros. (2006) Hemiplegic Migraine: Clinical Features, Links with Basilar-type Migraine, Current and Future Treatment. Headache Currents 3:4, 86-96
CrossRef100
Lynn MCKEOWN, Philip ROBINSON, Owen T JONES. (2006) Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits1. Acta Pharmacologica Sinica 27:7, 799-812
CrossRef101
Shazia K. Afridi, Peter J. Goadsby. (2006) Neuroimaging of migraine. Current Pain and Headache Reports 10:3, 221-224
CrossRef102
Michael G Hanna. (2006) Genetic neurological channelopathies. Nature Clinical Practice Neurology 2:5, 252-263
CrossRef103
Frédéric Bourdain, Emmanuelle Apartis, Jean-Marc Trocello, Jean-Sébastien Vidal, Pascal Masnou, Laurent Vercueil, Marie Vidailhet. (2006) Clinical analysis in familial cortical myoclonic tremor allows differential diagnosis with essential tremor. Movement Disorders 21:5, 599-608
CrossRef104
Kaate R J Vanmolkot, Esther E Kors, Ulku Turk, Dylsad Turkdogan, Antoine Keyser, Ludo A M Broos, Sima Kheradmand Kia, Jeroen J M W van den Heuvel, David F Black, Joost Haan, Rune R Frants, Virginia Barone, Michel D Ferrari, Giorgio Casari, Jan B Koenderink, Arn M J M van den Maagdenberg. (2006) Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. European Journal of Human Genetics 14:5, 555-560
CrossRef105
Malene Kirchmann, Lise Lykke Thomsen, Jes Olesen. (2006) The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 141B:3, 250-256
CrossRef106
H. P. H. Kremer. (2006) Een kwestie van komen en gaan: neurologische aandoeningen ten gevolge van ionkanaalmutaties. Tijdschrift voor kindergeneeskunde 74:2, 97-103
CrossRef107
Scott D. Z. Eggers. (2006) Migraine-related vertigo: Diagnosis and treatment. Current Neurology and Neuroscience Reports 6:2, 106-115
CrossRef108
M Sparaco, M Feleppa, RB Lipton, AM Rapoport, ME Bigal. (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26:4, 361-372
CrossRef109
C. Lampl, S. Marecek. (2006) Migraine and stroke - why do we talk about it?. European Journal of Neurology 13:3, 215-219
CrossRef110
F Pierelli, GS Grieco, F Pauri, C Pirro, G Fiermonte, A Ambrosini, A Costa, MG Buzzi, M Valoppi, C Caltagirone, G Nappi, FM Santorelli. (2006) A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia 26:3, 324-328
CrossRef111
Alessandra Tonelli, Maria Grazia D'Angelo, Roberto Salati, Laura Villa, Chiara Germinasi, Tiziano Frattini, Giovanni Meola, Anna Carla Turconi, Nereo Bresolin, Maria Teresa Bassi. (2006) Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene. Journal of the Neurological Sciences 241:1-2, 13-17
CrossRef112
Malene Kirchmann Eriksen, Lise Lykke Thomsen, Jes Olesen. (2006) Implications of Clinical Subtypes of Migraine With Aura. Headache: The Journal of Head and Face Pain 46:2, 286-297
CrossRef113
K. R. J. Vanmolkot, H. Stroink, J. B. Koenderink, E. E. Kors, J. J. M. W. van den Heuvel, E. H. van den Boogerd, A. H. Stam, J. Haan, B. B. A. De Vries, G. M. Terwindt, R. R. Frants, M. D. Ferrari, A. M. J. M. van den Maagdenberg. (2006) Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2ATP1A2 mutation. Annals of Neurology 59:2, 310-314
CrossRef114
Robert W. Baloh. (2006) Migraine and Vertigo: Epidemiology, Genetics, and Mechanism(s). Headache Currents 3:1, 1-7
CrossRef115
Johann Caspar Rüegg. (2005) Neurophysiologie psychosomatischer Schmerzen. Psychotherapie Forum 13:4, 136-142
CrossRef116
MS Berilgen, S Bulut, M Gonen, A Tekatas, E Dag, B Mungen. (2005) Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 25:11, 1048-1053
CrossRef117
Sian D. Spacey, Kaate R. J. Vanmolkot, Colleen Murphy, Arn M. J. M. van den Maagdenberg, Robin G. Y. Hsiung. (2005) Familial Hemiplegic Migraine Presenting as Recurrent Encephalopathy in a Native Indian Family. Headache: The Journal of Head and Face Pain 45:9, 1244-1249
CrossRef118
E. E. Benarroch. (2005) Neuron-Astrocyte Interactions: Partnership for Normal Function and Disease in the Central Nervous System. Mayo Clinic Proceedings 80:10, 1326-1338
CrossRef119
Nicholas P Davies, Louise H Eunson, Michael G Hanna. 2005. Ion Channels and Human Disorders. .
CrossRef120
Marie-Germaine Bousser, K Michael A Welch. (2005) Relation between migraine and stroke. The Lancet Neurology 4:9, 533-542
CrossRef121
Tatsuya Takahashi, Nobutaka Arai, Megumi Shimamura, Yume Suzuki, Sumimasa Yamashita, Hiroko Iwamoto, Yoshiaki Inayama, Youichi Kameda, Yoshiyuki Kuroiwa. (2005) Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation. Neuropathology 25:3, 228-234
CrossRef122
Dale R. Nyholt, Katherine I. Morley, Manuel A.R. Ferreira, Sarah E. Medland, Dorret I. Boomsma, Andrew C. Heath, Kathleen R. Merikangas, Grant W. Montgomery, Nicholas G. Martin. (2005) Genomewide Significant Linkage to Migrainous Headache on Chromosome 5q21. The American Journal of Human Genetics 77:3, 500-512
CrossRef123
Peter J Goadsby, Dimitri M Kullmann. (2005) Another migraine gene. The Lancet 366:9483, 345-346
CrossRef124
Martin Dichgans, Tobias Freilinger, Gertrud Eckstein, Elena Babini, Bettina Lorenz-Depiereux, Saskia Biskup, Michel D Ferrari, Jürgen Herzog, Arn MJM van den Maagdenberg, Michael Pusch, Tim M Strom. (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. The Lancet 366:9483, 371-377
CrossRef125
Lars Edvinsson, Rolf Uddman. (2005) Neurobiology in primary headaches. Brain Research Reviews 48:3, 438-456
CrossRef126
J. Haan, E. E. Kors, Kaate R. J. Vanmolkot, Arn M. J. M. Maagdenberg, Rune R. Frants, M. D. Ferrari. (2005) Migraine genetics: An update. Current Pain and Headache Reports 9:3, 213-220
CrossRef127
Jeffrey L. Noebels. (2005) Calcium Channel "Gaiting" and Absence Epilepsy. Epilepsy Currents 5:3, 95-97
CrossRef128
David W. Dodick. (2005) Migraine as a Risk Factor for White Matter Lesions, Silent Infarctions, and Ischemic Stroke. Headache Currents 2:3, 58-61
CrossRef129
Peter J Goadsby. (2005) Migraine Pathophysiology. Headache: The Journal of Head and Face Pain 45:s1, S14-S24
CrossRef130
Yukiko TADA, Kiyoshi NEGORO, Masaaki ABE, Jun-ichi OGASAWARA, Motoharu KAWAI, Mitsunori MORIMATSU. (2005) A Patient of Migraine-like Headache with Amnesia, Pleocytosis and Transient Hypoperfusion of Cerebral Blood Flow. Internal Medicine 44:7, 743-746
CrossRef131
LL Thomsen, J Olesen. (2004) Sporadic hemiplegic migraine. Cephalalgia 24:12, 1016-1023
CrossRef132
David F. Black, Simon Kung, Christopher L. Sola, Michael J. Bostwick, Jerry W. Swanson. (2004) Familial Hemiplegic Migraine, Neuropsychiatric Symptoms, and Erdheim-Chester Disease. Headache: The Journal of Head and Face Pain 44:9, 911-915
CrossRef133
Deacon E. Harle, Bruce J. W. Evans. (2004) The optometric correlates of migraine. Ophthalmic and Physiological Optics 24:5, 369-383
CrossRef134
Maria Spadaro, Simona Ursu, Frank Lehmann-Horn, Veneziano Liana, Antonini Giovanni, Giunti Paola, Marina Frontali, Karin Jurkat-Rott. (2004) A G301R Na+/K+-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 5:3, 177-185
CrossRef135
S Oberndorfer, C Wober, C Nasel, S Asenbaum, H Lahrmann, B Fueger, W Grisold. (2004) Familial hemiplegic migraine: follow-up findings of diffusion-weighted magnetic resonance imaging (MRI), perfusion-MRI and [99mTc] HMPAO-SPECT in a patient with prolonged hemiplegic aura. Cephalalgia 24:7, 533-539
CrossRef136
Hans-Christoph Diener. (2004) Advances in the field of headache 2003/2004. Current Opinion in Neurology 17:3, 271-273
CrossRef137
Esther E Kors, Kaate RJ Vanmolkot, Joost Haan, Rune R Frants, Arn MJM van den Maagdenberg, Michel D Ferrari. (2004) Recent findings in headache genetics. Current Opinion in Neurology 17:3, 283-288
CrossRef138
Jes Olesen, Richard B Lipton. (2004) Headache classification update 2004. Current Opinion in Neurology 17:3, 275-282
CrossRef139
Joost Haan, Esther E. Kors, Arn M. J. M. Maagdenberg, Kaate R. J. Vanmolkot, Gisela M. Terwindt, Rune R. Frants, Michel D. Ferrari. (2004) Toward a molecular genetic classification of familial hemiplegic migraine. Current Pain and Headache Reports 8:3, 238-243
CrossRef140
David F. Black. (2004) Sporadic hemiplegic migraine. Current Pain and Headache Reports 8:3, 223-228
CrossRef141
Dan A Svensson. (2004) Etiology of primary headaches: the importance of genes and environment. Expert Review of Neurotherapeutics 4:3, 415-424
CrossRef142
Daniel Martı́n Fernández-Mayoralas, Nuria Muñoz-Jareño, Marı́a Sagrario Manzano-Palomo, Jaime Campos-Castelló. (2004) Acute hemiparesis in a boy with type 1 diabetes. European Journal of Paediatric Neurology 8:3, 161-164
CrossRef143
Jean Schoenen, Peter S Sándor. (2004) Headache with focal neurological signs or symptoms: a complicated differential diagnosis. The Lancet Neurology 3:4, 237-245
CrossRef144
Arn M.J.M van den Maagdenberg, Daniela Pietrobon, Tommaso Pizzorusso, Simon Kaja, Ludo A.M Broos, Tiziana Cesetti, Rob C.G van de Ven, Angelita Tottene, Jos van der Kaa, Jaap J Plomp, Rune R Frants, Michel D Ferrari. (2004) A Cacna1a Knockin Migraine Mouse Model with Increased Susceptibility to Cortical Spreading Depression. Neuron 41:5, 701-710
CrossRef145
Michael A. Moskowitz, Hayrunnisa Bolay, Turgay Dalkara. (2004) Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Annals of Neurology 55:2, 276-280
CrossRef146
Stephen D Silberstein. (2004) Migraine. The Lancet 363:9406, 381-391
CrossRef147
H.C. Diener, K.M.A. Welch, J.P. Mohr. 2004. Migraine and Stroke. , 629-640.
CrossRef148
Guruswami Arunagiri, Shanmugam Santhi. (2003) Migraine: an ophthalmologist's perspective. Current Opinion in Ophthalmology 14:6, 344-352
CrossRef149
Ásgeir Björnsson, Grétar Gudmundsson, Einar Gudfinnsson, María Hrafnsdóttir, John Benedikz, Svanhildur Skúladóttir, Kristleifur Kristjánsson, Michael L. Frigge, Augustine Kong, Kári Stefánsson, Jeffrey R. Gulcher. (2003) Localization of a Gene for Migraine without Aura to Chromosome 4q21. The American Journal of Human Genetics 73:5, 986-993
CrossRef150
Ll Thomsen, E Ostergaard, Sf Romer, I Andersen, Mk Eriksen, J Olesen, Mb Russell. (2003) Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia 23:9, 921-928
CrossRef151
RICARDO A. MASELLI, WENDY BOOKS, VANESSA DUNNE. (2003) Effect of Inherited Abnormalities of Calcium Regulation on Human Neuromuscular Transmission. Annals of the New York Academy of Sciences 998:1, 18-28
CrossRef152
Kaate R. J. Vanmolkot, Esther E. Kors, Jouke-Jan Hottenga, Gisela M. Terwindt, Joost Haan, Wil A. J. Hoefnagels, David F. Black, Lodewijk A. Sandkuijl, Rune R. Frants, Michel D. Ferrari, Arn M. J. M. Van Den Maagdenberg. (2003) Novel mutations in the Na+, K+-ATPase pump geneATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Annals of Neurology 54:3, 360-366
CrossRef153
Kristine M. Chapman, Blazej I. Szczygielski, Cory Toth, Andrew Woolfenden, Gordon Robinson, Terrance P. Snutch, Sian D. Spacey. (2003) Pseudomigraine With Lymphocytic Pleocytosis: A Calcium Channelopathy? Clinical Description of 10 Cases and Genetic Analysis of the Familial Hemiplegic Migraine Gene CACNA1A. Headache: The Journal of Head and Face Pain 43:8, 892-895
CrossRef154
L. L. Thomsen, J. Olesen, M. B. Russell. (2003) Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. European Journal of Neurology 10:4, 421-427
CrossRef155
P. Friederich. (2003) Basic concepts of ion channel physiology and anaesthetic drug effects. European Journal of Anaesthesiology 20:5, 343-353
CrossRef156
Esther Kors, Joost Haan, Michel Ferrari. (2003) Migraine genetics. Current Pain and Headache Reports 7:3, 212-217
CrossRef157
J. Jay Gargus. (2003) Unraveling Monogenic Channelopathies and Their Implications for Complex Polygenic Disease. The American Journal of Human Genetics 72:4, 785-803
CrossRef158
Thomas Wieser, Christoph Mueller, Stefan Evers, Stephan Zierz, Thomas Deufel. (2003) Absence of Known Familial Hemiplegic Migraine (FHM) Mutations in the CACNA1A Gene in Patients with common Migraine: Implications for Genetic Testing. Clinical Chemistry and Laboratory Medicine 41:3, 272-275
CrossRef159
D. Soragna, A. Vettori, G. Carraro, E. Marchioni, G. Vazza, S. Bellini, R. Tupler, F. Savoldi, M.L. Mostacciuolo. (2003) A Locus for Migraine without Aura Maps on Chromosome 14q21.2-q22.3. The American Journal of Human Genetics 72:1, 161-167
CrossRef160
A Gutschalk. (2002) Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine. Neuroscience Letters 332:2, 115-118
CrossRef161
Anne Ducros, Elisabeth Tournier-Lasserve, Marie-Germaine Bousser. (2002) The Genetics of Migraine. The Lancet Neurology 1:5, 285-293
CrossRef162
N J Giffin, S Benton, P J Goadsby. (2002) Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Developmental Medicine & Child Neurology 44:7, 490-493
CrossRef163
Esther E. Kors, Arn M.J.M. van den Maagdenberg, Jaap J. Plomp, Rune R. Frants, Michel D. Ferrari. (2002) Calcium channel mutations and migraine. Current Opinion in Neurology 15:3, 311-316
CrossRef164
L Lykke Thomsen, M Kirchmann Eriksen, S Faerch Romer, I Andersen, E Ostergaard, N Keiding, J Olesen, MB Russell. (2002) An epidemiological survey of hemiplegic migraine. Cephalalgia 22:5, 361-375
CrossRef165
Peter J. Goadsby. (2002) Headache. Current Opinion in Neurology 15:3, 285-286
CrossRef166
Peter S. Sandor, Anna Ambrosini, Reto M. Agosti, Jean Schoenen. (2002) Genetics of Migraine: Possible Links to Neurophysiological Abnormalities. Headache: The Journal of Head and Face Pain 42:5, 365-377
CrossRef167
M WESSMAN, M KALLELA, M KAUNISTO, P MARTTILA, E SOBEL, J HARTIALA, G OSWELL, S LEAL, J PAPP, E HAMALAINEN. (2002) A Susceptibility Locus for Migraine with Aura, on Chromosome 4q24. The American Journal of Human Genetics 70:3, 652-662
CrossRef168
Robert W. Baloh. (2002) Episodic vertigo: central nervous system causes. Current Opinion in Psychiatry 15:1, 17-21
CrossRef169
Nicholas P Davies, Michael G Hanna. (2001) Inherited muscle and brain channelopathies. Expert Review of Neurotherapeutics 1:2, 247-265
CrossRef170
Hoffman, Eric P., . (2001) Hemiplegic Migraine — Downstream of a Single-Base Change. New England Journal of Medicine 345:1, 57-59
Full Text
